@JomboyMediaFB Slow the speed down, you can see the runner was not tackled he just lunged for the first down. Coach was down field looking in the hole from a pretty good angle he saw it developed all the way. Beta runners think get first down, Alpha runners always thinking homerun. Just saying.
$HUMA 10 year time horizon for me; The TAM for Dialysis Access (Near-Term TAM), Coronary Artery Bypass Grafting (CABG - Mid-Term TAM), Biovascular Pancreas (Long-Term TAM). This is my thesis for taking a long position (350k shares) @ $1.06 cost basis. Good luck my fellow longs.
$HUMA up 14.5% over the last 2 weeks, let's keep stacking these up weeks. I'm long HUMA (.1274%) excited for the future. Humacyte, Inc. (HUMA) is scheduled to release its Q2 2026 financial results on Wednesday, August 12, 2026, at 8:00 a.m. Eastern Time, before the market opens.
@ximiXian6i@JosephStocks714 The buys listed (WBA, PARA, HUMA ร3) are not new 2026 trades. They are delayed disclosures of purchases made in March 2024 (filed very late around Aug 5, 2026). Tubervilleโs most recent actual trades were sells in early June 2026. No confirmed new HUMA/WBA/PARA buys this year